Disease: cutaneous infections

Optimized protein extraction protocol from human skin samples

mycolabadmin

Researchers developed an improved method for extracting and analyzing proteins from human skin samples. Using specialized equipment and chemical treatments, they were able to identify about 6,000 different proteins in skin tissue, which is significantly more than previous methods could detect. This new protocol is particularly useful for studying skin diseases like fungal infections and could help identify new treatments by revealing how proteins change in diseased skin.

Read More »

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Mucormycosis is a dangerous fungal infection that kills many immunocompromised patients. Researchers analyzed the outer layer (cell wall) of three common disease-causing fungi and discovered that their surfaces contain sugar-like molecules that trigger strong inflammatory responses from the immune system. This excessive inflammation may actually contribute to the disease’s severity, suggesting that controlling inflammation alongside antifungal treatment might improve patient outcomes.

Read More »

Dermatophytes adaptation to the human host exemplified by Microsporum canis

mycolabadmin

Researchers studied how fungi that normally infect cats and dogs are adapting to infect humans. By comparing the genes of zoophilic (animal-loving) and anthropophilic (human-loving) Microsporum species, they found that human-adapted strains have developed specific proteins that help them survive in the acidic environment of human skin. These fungi have evolved special enzymes for breaking down keratin and tolerating the lipid-rich, acidic conditions of human skin better than their animal-loving relatives.

Read More »

Identification of Non-fumigatus Aspergillus Species in Clinical Samples from Southern California

mycolabadmin

Researchers studied fungal infections caused by Aspergillus in Southern California from 2012 to 2023, examining over 10,000 patients. They found that species other than the commonly known A. fumigatus were actually more prevalent in clinical samples, particularly A. niger from skin and nail infections. Importantly, these non-fumigatus species showed seasonal patterns and some carry resistance to standard antifungal medications, suggesting doctors may need to adjust their treatment approaches for fungal infections.

Read More »

Identification of Non-fumigatus Aspergillus Species in Clinical Samples from Southern California

mycolabadmin

Researchers in Southern California studied fungal infections caused by Aspergillus, a common mold that can infect humans. They found that species other than the traditionally dangerous A. fumigatus are now being detected more frequently in patient samples, particularly from skin and respiratory infections. These non-fumigatus species showed interesting seasonal patterns and some may be resistant to standard antifungal treatments, suggesting doctors may need to adjust their treatment strategies.

Read More »
Scroll to Top